ALS

Costly new ALS treatment approvedFDA recently approved the first new treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, in more than 20 years.
EyeControl allows people with ALS to communicate with their eyes
EyeControl allows people with ALS to communicate with their eyesA new wearable device called EyeControl aims to give a voice to those who are unable to communicate by allowing them to speak using their eyes.
Does type 2 diabetes protect against Lou Gehrig’s?New research suggests that patients with type 2 diabetes, but not obesity, may have a lower risk for amyotrophic lateral sclerosis (ALS).
FDA fast tracks ALS drugFDA has designated new ALS stem cell therapy from BrainStorm Cell Therapeutics as a “fast-track” product.
FDA drug approvals - October 2014
FDA drug approvals - October 2014FDA actions in brief, fast-track designations, priority review.